Glargine
New Insulin Analog<br
new insulin analogs to be introduced this year was
<br
insulin analog <br
technology. A glycine substitution on the A-chain <br
extension on the B-chain of 2 arginine residues creates a
shift in <br
solubility of this insulin at <br
Furthermore, the hexomeric structure of this molecule is
<br
monomers. <br
and prolonged absorption.The <br
insulin glargine is flat and lasts 24 hours. Perhaps even
more <br
consistent, compared with the other <br
insulins, NPH and Ultralente. The need to separate basal
<br
important as insulin <br
continues to evolve.Studies for insulin <br
common theme — a reduction of hypoglycemia when
compared <br
and more consistent absorption, <br
should not be surprising.<br
huh?<br
June 23rd, 2004 at 1:48 pm
This Insulin was actually approved by the FDA
LAST year. It was supposed to be introduced into the
US by the first of 2001 but stronger than normal
demand in Europe has postponed intro until later this
Summer in US> All news about this insulin has been
super positive ergo the huge demand in Europe. I
personally cannot wait for it to come to market here. John
June 24th, 2004 at 3:23 pm
The proprietary name for Insulin glargine is Lantus. Here is the web site
www.Lantus.com